In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity
- Merylin Cottagiri
- , Maeva Nyandjo
- , Matthew Stephens
- , Joel J. Mantilla
- , Hirohisa Saito
- , Ian R. Mackay
- , Noel R. Rose
- , Dolores B. Njoku
Research output: Contribution to journal › Article › peer-review
16
Link opens in a new tab
Scopus
citations